Title

Multiple-dose,Double-blind,Placebo-controlled Study of Sodium Oxybate in Patients With Essential Tremor
Multiple-dose, Double-blind, Placebo-controlled, Crossover Study to Compare the Pharmacokinetics, Pharmacodynamics, Safety, and Tolerability of Sodium Oxybate (Xyrem) in Subjects With Moderate to Severe Essential Tremor
  • Phase

    Phase 2
  • Study Type

    Interventional
  • Intervention/Treatment

    sodium oxybate ...
  • Study Participants

    19
To determine the relationship between drug plasma levels and safety, tolerability and efficacy in patients with essential tremors after dosing with Sodium oxybate
Study Started
Dec 31
2007
Primary Completion
Aug 31
2008
Study Completion
Dec 31
2008
Results Posted
Jan 23
2012
Estimate
Last Update
Jan 23
2012
Estimate

Drug Sodium Oxybate

Dose 1

Drug Sodium Oxybate

Dose 2

Other Placebo

Dose 3

1 Experimental

2 Experimental

3 Placebo Comparator

Criteria

Inclusion Criteria:

Diagnosis of moderate or severe classic essential tremor (bilateral, largely symmetric postural or kinetic tremor involving hands and forearms.
Willingness to abstain from ethanol and caffeine intake for at least 48 hours prior to Days 1 and 4 and on inpatient days

Exclusion Criteria:

Subjects with a clinically significant unstable medical abnormality, chronic disease or history or presence of significant hepatic, renal, endocrine, cardiovascular, gastrointestinal, pulmonary, psychiatric, or metabolic disease or any other abnormality
Subjects who are on sodium-restricted diets
Subjects with a known history of sleep apnea

Summary

Sodium Oxybate 1.5 Grams (A)

Sodium Oxybate 3 Grams (B)

Placebo (C)

All Events

Event Type Organ System Event Term Sodium Oxybate 1.5 Grams (A) Sodium Oxybate 3 Grams (B) Placebo (C)

Modified FTM(Fahn-Tolosa-Marin) Essentials Tremor Rating Scale, Sum of All Essential Rating Tremor Scales Including Voice Tremor

The modified FTM sum of all essential rating tremor scales including voice tremor includes: the tremor rating taken for the left & right hands individually at rest, with posture (arms outstretched), with action (finger to nose). It also includes an evaluation of voice with scores for AAA & EEE sounds, an action evaluation of left & right hands pouring, bringing liquids to mouth, drawing large & small spirals. Scores for indiviuals items range from 0 (no tremor) to 4 (severe tremor). The sum ranges from 0 (no tremor) to 72 points (higher amplitude/more tremors).

Sodium Oxybate 1.5 Grams (A)

13.4
Points (Least Squares Mean)
90% Confidence Interval: 9.05 to 17.65

Sodium Oxybate 3 Grams (B)

10.8
Points (Least Squares Mean)
90% Confidence Interval: 6.5 to 15.1

Placebo (C)

13.0
Points (Least Squares Mean)
90% Confidence Interval: 8.66 to 17.28

Age Continuous

60.0
years (Mean)
Standard Deviation: 8.72

Race (NIH/OMB)

Region of Enrollment

Sex: Female, Male

Period 1 (Day 1)

Regimen A, Then B, Then C

Regimen A, Then C, Then B

Period 2 (Day 2)

Regimen A, Then B, Then C

Regimen A, Then C, Then B

Period 3 (Day 3)

Regimen A, Then B, Then C

Regimen A, Then C, Then B

Drop/Withdrawal Reasons

Regimen A, Then B, Then C